Everyday, millions of inadvertent particles may be infused into patients during hospitalization, especially in intensive care units, and are likely to worsen the pathogenetic effect in vulnerable patients. (1,2)
We make the invisible visible and challenged our Posidyne™ IV in-line filters with 100 µm polystyrene red labeled particles. Watch this video and see how our IV in-line filters retain the particles.
Watch this video: How IV in-line filters retain particles
References
- Perez M, Décaudin B, Chahla WA, Nelken B, Barthélémy C, Lebuffe G, et al. In vitro analysis of overall particulate contamination exposure during multidrug IV therapy: impact of infusion sets. Pediatr Blood Cancer. 2015;62(6):1042-1047. doi:10.1002/pbc.25442.
- Perez M, Maigyu-Foinard A, Barthélémy C, Décaudin B, Odou P. Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharm Technol Hosp Pharm. 2016;1(2):91-103. doi.org.10.1515/pthp-2016-0004.
Author bio
Dr. Volker Luibl, MBA
Dr. Luibl is a Demand Generation Marketing Manager in medical device and clinical science at Cytiva.